Data News > Top gainers in Social Responsible Investing - INTC, MRK, EL, BMY, PFE

Top gainers in Social Responsible Investing - INTC, MRK, EL, BMY, PFE

By KlickAnalytics Data Insights  |   December 31, 2024 04:39PM ET

Following are the Top 5 companies based on their one-day percentage change within the 'Social Responsible Investing' theme.

Intel Corporation (INTC)

INTC is trading UP for the last 1 days, and it at trading at $20.06 with volume of 43,211,671 and a one day change of $0.24 (1.19%). Intel Corporation has a 52-week low of 18.51 and a 52-week high of $51.28. The business's 50-day moving average price is $23.39 and its 200 day moving average price is $25.37. The firm has a market cap of $86 million, a P/E ratio of 30.77, and a beta of 1.03.

Top news headlines for INTC

  • During another excellent year for the broad U.S. stock market, 98 stocks among the S&P 500 showed double-digit declines
  • Intel lost 60% of its value in 2024, the biggest drop in its 53 years as a public company. Broadcom's stock price more than doubled, with its best month ever coming in December after the company's earnings report.
  • Like Pat Gelsinger, Boeing's Kelly Ortberg is a technically minded leader tasked with rescuing a storied American manufacturer damaged by bean counters.

  • For more information on INTC:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Merck & Co., Inc. (MRK)

    MRK is trading UP for the last 1 days, and it at trading at $99.39 with volume of 4,561,857 and a one day change of $1.02 (1.04%). Merck & Co., Inc. has a 52-week low of 94.48 and a 52-week high of $134.63. The business's 50-day moving average price is $101.52 and its 200 day moving average price is $115.78. The firm has a market cap of $249 million, a P/E ratio of 144.51, and a beta of 0.41.

    Top news headlines for MRK

  • UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's therapy to treat a rare lung condition called pulmonary arterial hypertension.
  • The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb (BMY -2.81%) and Merck & Co. (MRK -1.33%) stand out for their combination of above-average dividend yields and proven business models.

  • For more information on MRK:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • The Estée Lauder Companies Inc. (EL)

    EL is trading UP for the last 1 days, and it at trading at $74.88 with volume of 1,422,935 and a one day change of $0.69 (0.93%). The Estée Lauder Companies Inc. has a 52-week low of 62.47 and a 52-week high of $159.71. The business's 50-day moving average price is $73.63 and its 200 day moving average price is $93.94. The firm has a market cap of $27 million, a P/E ratio of 74.16, and a beta of 1.04.

    For more information on EL:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Bristol-Myers Squibb Company (BMY)

    BMY is trading UP for the last 1 days, and it at trading at $56.58 with volume of 5,074,966 and a one day change of $0.52 (0.92%). Bristol-Myers Squibb Company has a 52-week low of 39.35 and a 52-week high of $61.08. The business's 50-day moving average price is $56.29 and its 200 day moving average price is $48.74. The firm has a market cap of $116 million, a P/E ratio of 0.00, and a beta of 0.44.

    Top news headlines for BMY

  • Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
  • The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb (BMY -2.81%) and Merck & Co. (MRK -1.33%) stand out for their combination of above-average dividend yields and proven business models.

  • For more information on BMY:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Pfizer Inc. (PFE)

    PFE is trading UP for the last 1 days, and it at trading at $26.53 with volume of 22,455,622 and a one day change of $0.11 (0.40%). Pfizer Inc. has a 52-week low of 24.48 and a 52-week high of $31.54. The business's 50-day moving average price is $26.79 and its 200 day moving average price is $28.46. The firm has a market cap of $149 million, a P/E ratio of 0.00, and a beta of 0.62.

    Top news headlines for PFE

  • The small-cap won't receive an expected payout in the first quarter, creating a cash overhang.
  • Sangamo Therapeutics (SGMO) shares cratered more than 50% Tuesday, a day after the biopharma firm announced that Pfizer (PFE) had pulled out of its deal to co-develop a hemophilia drug.
  • On Monday, Sangamo Therapeutics, Inc. SGMO regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for moderately severe to severe hemophilia A that it has co-developed with and licensed to Pfizer Inc PFE.
  • The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents protecting their proprietary drugs expire.
  • Pharmaceutical giant Pfizer Inc. NYSE: PFE stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something causes shares to slide right back down.

  • For more information on PFE:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.